<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03271580</url>
  </required_header>
  <id_info>
    <org_study_id>1808802536</org_study_id>
    <nct_id>NCT03271580</nct_id>
  </id_info>
  <brief_title>Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing</brief_title>
  <official_title>Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about biofilm and to see how it affects diabetic&#xD;
      wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime&#xD;
      enclosed group. This grouping of bacteria is called a biofilm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is one study visit with a 14-week follow-up that will take place during the&#xD;
      participants standard of care visit at the Indiana University Health Comprehensive Wound&#xD;
      Center (CWC). The following procedures will take place once your appointment has been&#xD;
      completed:&#xD;
&#xD;
        -  Informed consent will be signed (if not previously signed)&#xD;
&#xD;
        -  A hemoglobin A1c drawn will be taken by research personnel, if one has not been done&#xD;
           within the last 90 days to check your average blood sugar level.&#xD;
&#xD;
        -  An Ankle Brachial Index (ABI) will be obtained if the participant has a leg wound. This&#xD;
           is to ensure that participants have adequate blood flow to your wound. This is a&#xD;
           non-invasive test which measures blood pressure in both of the participants arms and&#xD;
           ankles.&#xD;
&#xD;
        -  Demographics (such as your name and address and phone number, age), medical history,&#xD;
           current medications, current standard of care labs, and wound data (measurements, cause&#xD;
           of the wound, wound culture, assessments, treatments, and duration) will be recorded.&#xD;
           The participant's medical record number will also be recorded.&#xD;
&#xD;
        -  A photo of the wound site will be taken.&#xD;
&#xD;
        -  Wound Vac Collection - The wound vac sponge will be collected (waste by product of the&#xD;
           therapy) by the research staff.&#xD;
&#xD;
        -  An optional two 3 mm punch tissue biopsies will be obtained from the participant's&#xD;
           provider. To perform the biopsy, the area surrounding the wound will first be numbed&#xD;
           using a local anesthetic agent that will be injected at the wound site. Then, a&#xD;
           pencil-like instrument will be used to remove a small, thin cylinder of tissue. Each&#xD;
           biopsy is about the size of this dot. After the tissue is removed, a sterile gauze will&#xD;
           be placed on the area to stop any minor bleeding that may occur. The biopsies will be&#xD;
           looked at in the laboratory to look at the microorganisms. You will not receive the&#xD;
           results of the completed laboratory analysis. (Note: If two biopsies cannot be obtained&#xD;
           per your physician's discretion, only one biopsy, debridement tissue (dead tissue that&#xD;
           is removed from your wound) or no tissue will be obtained, and/or culture swabs (your&#xD;
           wound will be swabbed with something like a Q-tip to collect cells to test for bacteria&#xD;
           or other organisms in the wound) will be collected to test for infection.)&#xD;
&#xD;
      During the 14-week follow-up visit, research staff will review the participant's medical&#xD;
      chart to determine the final status of the wound. If the participant does not return to the&#xD;
      CWC at 14 weeks, the last CWC visit will be documented as the wound check follow-up. This&#xD;
      does not require the participant to return for an extra study visit. This information will&#xD;
      only be collected from their medical chart if available:&#xD;
&#xD;
        -  Final status of the wound (healing, not healing, healed)&#xD;
&#xD;
        -  Wound data (measurements), treatments, and any standard of care labs will be obtained&#xD;
&#xD;
        -  A photo of your wound from the medical chart will be obtained (if available)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biofilm infection</measure>
    <time_frame>14 Weeks</time_frame>
    <description>Biofilm Infection using SEM and RT PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>macrophage phenotyping</measure>
    <time_frame>14 Weeks</time_frame>
    <description>Wound macrophage phenotypes using flowcytometry, RTPCR and RNA Seq</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Wound</condition>
  <condition>Bacterial Infections</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Infected Ulcer of Skin</condition>
  <arm_group>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <description>Diabetic patients with HbA1c&lt;9 with who have wound 4weeks or longer with infection with following interventions:&#xD;
Finger prick test for HbA1c measurement&#xD;
Punch biopsy&#xD;
VAC sponge collection&#xD;
Ankle brachial index</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
    <description>Diabetic patients with HbA1c&lt;9 who have wound 4 weeks or longer without infection with following interventions:&#xD;
Finger prick test for HbA1c measurement&#xD;
Punch biopsy&#xD;
VAC sponge collection&#xD;
Ankle brachial index</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Finger prick test for HbA1c measurement</intervention_name>
    <description>HbA1c measurement with finger prick method</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Punch Biopsy</intervention_name>
    <description>Wound site will be anaesthetized, by punch biopsy tissue will be collected, wound site will be monitored for bleeding(if bleeding Cautery will be used to stop bleeding).</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vac Sponge Collection</intervention_name>
    <description>NPWT sponge which is discarded as biological waste, will be collected for wound macrophage isolation</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ankle Brachial Index</intervention_name>
    <description>Blood pressure test</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Wound Vac Sponge, Wound Tissue biopsy&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Twenty-eight diabetic subjects with chronic foot ulcer(s) that are receiving Negative Wound&#xD;
        Pressure Therapy (NPWT) will be enrolled. Eighteen subjects will be infected and 10&#xD;
        subjects will be non-infected serving as the control for the study. The inclusion and&#xD;
        exclusion criteria were carefully selected to enroll diabetic patients who have wound&#xD;
        tissue oxygenation adequate to support wound healing.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 and above years old&#xD;
&#xD;
          2. Willing and able to provide informed consent&#xD;
&#xD;
          3. Willing and able to comply with protocol instructions, including biopsies and study&#xD;
             visits&#xD;
&#xD;
          4. Diabetics with an open wound&#xD;
&#xD;
          5. Receiving Negative Wound Pressure Therapy (NPWT)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inadequate arterial supply, as evidenced by any of the following (for wounds below the&#xD;
             knee):&#xD;
&#xD;
               1. TcOM &lt; 30mmHg&#xD;
&#xD;
               2. ABI &lt; 0.7&#xD;
&#xD;
               3. TBI &lt; 0.6&#xD;
&#xD;
          2. Women who are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sashwati Roy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Miller, CCRP</last_name>
    <phone>(317) 278-2720</phone>
    <email>amym@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sashwati Roy, PhD</last_name>
    <phone>(317) 278-2706</phone>
    <email>roysa@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IU Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Miller, CCRP</last_name>
      <phone>317-278-2720</phone>
      <email>amym@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Sashwati Roy, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Breen JD, Karchmer AW. Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am. 1995 Mar;9(1):11-24. Review.</citation>
    <PMID>7769212</PMID>
  </reference>
  <reference>
    <citation>Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep. 2006 Dec;6(6):439-45. Review.</citation>
    <PMID>17118226</PMID>
  </reference>
  <reference>
    <citation>James GA, Swogger E, Wolcott R, Pulcini Ed, Secor P, Sestrich J, Costerton JW, Stewart PS. Biofilms in chronic wounds. Wound Repair Regen. 2008 Jan-Feb;16(1):37-44. Epub 2007 Dec 13.</citation>
    <PMID>18086294</PMID>
  </reference>
  <reference>
    <citation>Hanke ML, Angle A, Kielian T. MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection. PLoS One. 2012;7(8):e42476. doi: 10.1371/journal.pone.0042476. Epub 2012 Aug 3.</citation>
    <PMID>22879997</PMID>
  </reference>
  <reference>
    <citation>Hanke ML, Heim CE, Angle A, Sanderson SD, Kielian T. Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J Immunol. 2013 Mar 1;190(5):2159-68. doi: 10.4049/jimmunol.1202348. Epub 2013 Jan 30. Erratum in: J Immunol. 2013 Jun 15;190(12):6709-10.</citation>
    <PMID>23365077</PMID>
  </reference>
  <reference>
    <citation>Neut D, Tijdens-Creusen EJ, Bulstra SK, van der Mei HC, Busscher HJ. Biofilms in chronic diabetic foot ulcers--a study of 2 cases. Acta Orthop. 2011 Jun;82(3):383-5. doi: 10.3109/17453674.2011.581265. Epub 2011 May 11.</citation>
    <PMID>21561305</PMID>
  </reference>
  <reference>
    <citation>Zhao G, Usui ML, Lippman SI, James GA, Stewart PS, Fleckman P, Olerud JE. Biofilms and Inflammation in Chronic Wounds. Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399. Review.</citation>
    <PMID>24527355</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2017</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Sashwati Roy</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Wound healing</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Inflammatory cells</keyword>
  <keyword>Macrophage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

